How Much Liquid Is in a Wegovy Pen? A Practical Dosage Guide

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection pens deliver measured doses of a GLP-1 receptor agonist that slows gastric emptying and reduces appetite signaling in the brain. Each pen is pre-filled with a specific volume of liquid, but the actual drug dose depends on the concentration strength and the dial setting selected by the patient.

Understanding Semaglutide Pen Liquid Volume

Brand-name Wegovy pens contain 1.5 mL of liquid per pre-filled injection pen. This 1.5 mL volume remains constant across all four strength tiers (0.25 mg, 0.5 mg, 1 mg, and 2.4 mg), but the concentration of semaglutide dissolved in that liquid changes. A 0.25 mg dose uses the same pen size as a 2.4 mg dose; only the drug concentration differs.

When patients dial their pen to select a dose, they are not changing the total volume injected significantly—they are controlling how much semaglutide is delivered through the needle. Most patients inject between 0.1 and 0.3 mL per shot, meaning a single pen can provide multiple doses before depletion. The visual dose window and click mechanism on the pen make it easy to track how much medication has been used.

How Dose Escalation Works Without Price Increases

Standard semaglutide protocols begin at 0.25 mg once weekly and escalate by 0.25 mg every four weeks until reaching a therapeutic dose or a maximum of 2.4 mg weekly. This titration strategy allows the body to adapt to GLP-1 activation, reducing nausea and gastrointestinal side effects. PlexusDx compounded semaglutide injection begins at $189/mo (or $149/mo on the 6-month plan), and that price holds steady as your dose climbs—your dose may need to go up, but your price won't.

Compounded semaglutide from licensed 503A pharmacies is made in a laboratory setting to match the same active pharmaceutical ingredient as brand products, but at a lower cost structure. Because PlexusDx prices are flat per compound regardless of strength or dose tier, patients avoid the financial burden of paying more as they progress through escalation weeks.

Injection Technique and Pen Administration

Semaglutide pens are designed for subcutaneous injection into the abdomen, thigh, or upper arm once per week. Patients receive training from their healthcare provider on needle angle, site rotation, and sterile technique. The needle is very fine (typically 29–32 gauge), and most patients report minimal discomfort after the first few injections. Injection sites should be rotated to prevent lipohypertrophy, a buildup of fatty tissue under the skin.

The pen's dial-and-click mechanism ensures accurate dosing without guesswork. Patients simply turn the dial until it aligns with their prescribed dose number, insert the needle at a 90-degree angle, press the injection button, and hold for 6 seconds to ensure full delivery. Each injection pen comes with written instructions and visual diagrams, though many providers also offer video demonstrations or nurse hotlines for technique questions.

Comparing Injection vs. Oral Semaglutide at PlexusDx

PlexusDx offers both compounded semaglutide injection (starting at $189/mo (or $149/mo on the 6-month plan)) and oral semaglutide (starting at $289/mo (or $249/mo on the 6-month plan)). Injectable semaglutide is absorbed directly into the bloodstream through subcutaneous tissue, achieving peak drug levels within 1–3 days of injection. Oral semaglutide must pass through the gastrointestinal tract and is absorbed less predictably, requiring specific dosing instructions (empty stomach, no food for 30 minutes after taking the tablet).

Clinical studies show that injectable semaglutide typically produces stronger weight-loss results than oral formulations at equivalent doses, though both are effective for appetite suppression and metabolic improvement. Injection therapy requires once-weekly dosing and injection supply management, while oral therapy requires daily adherence but offers needle-free convenience. The choice depends on patient preference, gastrointestinal tolerance, and weight-loss goals. PlexusDx accepts HSA and FSA funds for either format, and both are available in all 50 states without insurance.

Genetic Testing and Personalized Dose Selection

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) analyzes GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Genetic predispositions in the GLP-1 receptor pathway can influence how quickly a patient reaches satiety on a given dose and whether side effects like nausea are more or less pronounced. Patients with certain genetic profiles may achieve target weight loss on lower doses, potentially reducing gastrointestinal effects, while others may require a faster escalation schedule. Precision Peptide results help PlexusDx providers tailor the titration plan to each patient's unique metabolic blueprint, improving outcomes and tolerability.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $189/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much does a single Wegovy pen injection actually cost at PlexusDx?

PlexusDx compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan) with a flat pricing model—no matter which dose strength you use during titration, the monthly price stays the same. This means you can escalate from 0.25 mg to 2.4 mg without worrying about price increases. No insurance is required, and the medication is HSA/FSA eligible.

Why does the Wegovy pen contain 1.5 mL if most patients only inject 0.1–0.3 mL per week?

The 1.5 mL volume in each pre-filled pen is designed to provide multiple weekly doses across different strength concentrations. Because the drug is dissolved at different concentrations depending on the dose tier, a small volume of concentrated liquid contains a full therapeutic dose. This design minimizes pen size while allowing patients to progress through the entire escalation protocol without changing pen types.

Can I buy PlexusDx semaglutide injections without insurance or a membership fee?

Yes. PlexusDx serves all 50 states, requires no insurance, and charges no membership or consultation fees—only the monthly medication cost. HSA and FSA accounts are accepted, making compounded semaglutide injection an accessible option for uninsured and self-pay patients.

Is compounded semaglutide from a 503A pharmacy as safe as brand-name Wegovy?

Compounded semaglutide from licensed 503A pharmacies uses the same active pharmaceutical ingredient as brand products and follows strict FDA compounding standards. PlexusDx partners exclusively with accredited 503A compounding pharmacies (never 503B facilities). While compounded medications are not FDA-approved as finished products, they are legally manufactured, quality-tested, and clinically effective.

How does the Precision Peptide Genetic Test help optimize my semaglutide dose?

No — the Precision Peptide Genetic Test does not predict your response to Wegovy or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy 025 Mg 05 Ml Pen
• Ro Wegovy
• Mochi Wegovy
• Noom Wegovy

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.